Level Bio AB (publ) (NGM:LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.340
-0.002 (-0.58%)
At close: Apr 27, 2026
Level Bio AB Revenue
Level Bio AB had revenue of 9.02M SEK in the quarter ending March 31, 2026, with 15.56% growth. This brings the company's revenue in the last twelve months to 33.51M, up 21.98% year-over-year. In the year 2025, Level Bio AB had annual revenue of 32.36M with 28.94% growth.
Revenue (ttm)
33.51M
Revenue Growth
+21.98%
P/S Ratio
0.69
Revenue / Employee
3.35M
Employees
10
Market Cap
23.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.36M | 7.26M | 28.94% |
| Dec 31, 2024 | 25.10M | -999.39K | -3.83% |
| Dec 31, 2023 | 26.10M | -8.24M | -23.99% |
| Dec 31, 2022 | 34.33M | -9.63M | -21.91% |
| Dec 31, 2021 | 43.96M | 20.43M | 86.86% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Goobit Group AB | 240.28M |
| Qbrick AB | 32.66M |
| edyoutec AB | 17.05M |
| PolarCool AB | 2.40M |
| Nattaro Labs AB | 6.02M |
| Vaxxa AB | 77.45M |
| Transiro Holding AB | 28.46M |
| LightAir AB | 14.43M |